CD4 and prostate cancer: Recently, Mao et al16 evaluated peripheral blood lymphocyte subtypes and clinical outcomes of 135 prostate cancer patients and reported that an absolute CD4 T lymphocyte count of less than 255/μL is an unfavorable prognostic factor for prostate cancer survival.